Brachytherapy Market Revenue Trends, Company Profiles, Revenue Share Analysis 2026

The rise in the prevalence of cancer, adoption of technological advanced treatments, ongoing new product launch, and strategic collaboration, better healthcare facilities are key factors contributing to the high CAGR of the Brachytherapy market during the forecast period.

Market Size – USD 368.8 Million in 2018, Market Growth – CAGR of 4.7% Market Trends– Rise in research and development of efficient products

According to the current analysis of Reports and Data, the global Brachytherapy Market valued at USD 368.8 million in 2018 and is expected to reach USD 531.4 billion by the year 2026, at a CAGR of 4.7%. It is a treatment used for the treatment of malignancy; it is done by placing radioactive material inside the body; it is also called internal radiation. The therapy allows doctors to deliver high doses of radiation to specific parts of the body rather than using conventional forms of radiation therapy where radiation is given outside the body.  This process targets the tumor and reduces radiation to the nearby healthy tissue.

According to the reports of WHO, the global cancer burden had estimated to be about 18.1 million new cases and 9.6 million deaths by 2018. According to an estimation around 17 million registered breast cancer in 2017, wherein 10 million had prostate cancer in 2017 across the globe. Due to the rise in technological advancements, R&D investments are likely to propel the growth of the market; also, the increase in healthcare awareness are factors improving market growth. However, side effects obtained by the therapy, and availability of other alternative substitute therapies are the primary restraint to the market. North America had held significant market value in the year 2018, owing to the rise in the prevalence of malignancy, and an increase in the healthcare expenditure, and also government funding for better treatment of tumors.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2640

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

Key companies operating in the market and profiled in the report include:

Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2640

Further key findings from the report suggest

  • In 2018 the Journal of the American Medical for the treatment of prostate cancer registered the efficient usage of brachytherapy in combination with EBRT (external beam radiotherapy)
  • Recent advances have been done for the treatment of head, and neck soft tissue sarcoma (HNSTS) here the use of Radioactive I Seed (RIS) implantation brachytherapy is done. It is a type of low-dose-rate brachytherapy, characterized by delivering high radiation dose to tumor target while safely sparing the adjacent normal tissue, for improving the effectiveness HNSTS is combined with EBRT i.t is also useful in prostate cancer, lung cancer, pancreatic cancer, rectal cancer, cervical cancer, head, and neck cancer, and for rectal cancer, this treatment also has been given a referenced by NCCN Guidelines of Rectal Cancer in 2015 for rectal carcinoma.
  • Currently, clinical trials are being performed using interstitial brachytherapy for boosting the treatment of anal cancer in the year 2018 it was performed using Low Dose rate brachytherapy and also by high dose rate Brachytherapy.
  • High Dose rate brachytherapy was found to have the highest market share in the year 2018 based on segment of type as it more powerful form of internally delivered radiation therapy that destroys many types of the tumor; also it provides precise radiation therapy used alone or applied after surgery to help prevent recurrence of the tumor.
  • The AccuBoost Technique is non-invasive breast brachytherapy that reduces the chances of tumors in stage I and II breast cancer. It also helps in preventing the relapse as it kills the tumor bed. AccuBoost technique has driven the market and is likely to boost the market in India, as the survival rate for breast tumors continues to remain high.
  • By Application, segment prostate cancer registered a highest market share of about 40.6% in the year 2018. It is expected to reach a CAGR of 5.2%, which was the largest on account of the market.

Segments Covered in the report

Types Outlook (Revenue in Million USD; 2016–2026)

  • High Dose Rate (HDR) Brachytherapy
  • Low Dose Rate (LDR) Brachytherapy

Products Outlook (Revenue in Million USD; 2017–2024)

  • Brachytherapy After Loader
  • Brachytherapy Applicators
    • Intraluminal Applicators
    • Interstitial Applicators
    • Intraoperative and Surface Applicators
  • Brachytherapy Software

Applications Outlook (Revenue in Million USD; 2017–2024

  • Cervical cancer
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Other Cancers

End Use Outlook (Revenue in Million USD; 2017–2024)

  • Hospitals
  • Oncology Treatment Centers
  • Others

To know more about the report @ https://www.reportsanddata.com/report-detail/brachytherapy-market

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Furthermore, it consists information about individual segment of the Brachytherapy market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2640

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

Browse More Reports:

Stem Cells Market Size

Specialty Paper Market Share

Neuroscience Antibodies and Assays

Clinical Microbiology Market Size